US2005282852A1PendingUtilityA1

Preventive and therapeutic medicament for gastroesophageal reflux disease

Assignee: YAMAZAKI SATOSHIPriority: Feb 9, 2000Filed: Aug 31, 2005Published: Dec 22, 2005
Est. expiryFeb 9, 2020(expired)· nominal 20-yr term from priority
A61P 1/04C07D 495/04A61K 31/4743A61K 31/439A61K 31/55
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The compound of the following formula: wherein R 1 and R 2 independently represent a hydrogen atom or a lower alkyl group; A represents a group selected from the group consisting of 1-azabicyclo[3.2.2]nonyl group, 1-azabicyclo[2.2.2]octyl group, or an N-oxide thereof, or a pharmaceutically acceptable salt thereof or a hydrate thereof has both improving effect on enterokinetic functions and suppressing effect on acid secretion, and also is highly safe. Accordingly, the substance is useful as preventive or therapeutic medicament for a gastroesophageal reflux disease.

Claims

exact text as granted — not AI-modified
1 . A preventive or therapeutic medicament for a gastroesophageal reflux disease, which comprises as an active ingredient a thieno[3,2-b]pyridinecarboxamide derivative represented by the following formula (i) or a pharmaceutically acceptable salt thereof, or a hydrate thereof:  
     
       
         
         
             
             
         
       
     
     wherein R 1  and R 2  independently represent a hydrogen atom or a lower alkyl group; A represents a group selected from the group consisting of 1-azabicyclo[3.2.2]nonyl group, 1-azabicyclo[2.2.2]octyl group, or an N-oxide thereof.  
   
   
       2 . The preventive or therapeutic medicament according to  claim 1 , wherein R 1  and R 2  independently represent a hydrogen atom or methyl group, and A is 1-azabicyclo[2.2.2]oct-3-yl group or an N-oxide thereof.  
   
   
       3 . The preventive or therapeutic medicament according to  claim 1 , wherein said derivative is any one of N-(1-azabicyclo[2.2.2]oct-3-yl)-7-oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamide, (R)-N-(1-azabicyclo[2.2.2]oct-3-yl)-7-oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamide, or (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-7-oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamide.  
   
   
       4 . The preventive or therapeutic medicament according to  claim 1 , wherein said derivative is (R)-N-(1-azabicyclo[2.2.2]oct-3-yl)-7-oxo-4,7-dihydrothieno-[3,2-b]pyridine-6-carboxamide hydrochloride.  
   
   
       5 . The preventive or therapeutic medicament according to  claim 1 , wherein the gastroesophageal reflux disease is reflux esophagitis or non-ulcer dyspepsia.

Join the waitlist — get patent alerts

Track US2005282852A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.